De Bruyn, Astrid http://orcid.org/0000-0002-1252-4982
Gunst, Jan http://orcid.org/0000-0003-2470-6393
Goossens, Chloë http://orcid.org/0000-0002-0999-8562
Vander Perre, Sarah
Guerra, Gonzalo G.
Verbruggen, Sascha
Joosten, Koen
Langouche, Lies http://orcid.org/0000-0002-8564-6809
Van den Berghe, Greet http://orcid.org/0000-0002-5320-1362
Funding for this research was provided by:
Horizon 2020 Programme (AdvG-2017-785809)
Methusalem programme of the Flemish Government (METH14/06, METH14/06)
Agentschap voor Innovatie door Wetenschap en Technologie (IWT/070695/TBM)
Research Foundation Flanders (G.0C78.17N, G.0C78.17N)
Universitaire Ziekenhuizen Leuven, KU Leuven (Postdoctoral research fellowship)
Sophia Children's Hospital Foundation
Stichting Agis Zorginnovatie
Vereniging Trustfonds Erasmus Universiteit Rotterdam
European Society for Parenteral and Enteral Nutrition
Article History
Received: 8 May 2020
Accepted: 17 August 2020
First Online: 31 August 2020
Ethics approval and consent to participate
: This is a secondary analysis of the multicenter (Leuven, BE, Rotterdam, NL, Edmonton, CA) PEPaNIC randomized controlled trial (ClinicalTrials.gov NCT01536275, <i>n</i> = 1440). The institutional or national ethical review boards of the participating centers approved the study protocol. Written informed consent was obtained from the parents or legal guardians.
: Not applicable
: We declare no competing interests.